None listed
Conditions
Interventions
Control Intervention1: intraperitoneal 0.25% bupivacaine Vs intraperitoneal Magnesium sulphate & 0.25%
bupivacaine: At the end of surgery, patients who
- receive intraperitoneal instillation of 40ml o
Sponsors
DR RITHU VARKEY
Eligibility
Inclusion criteria
Inclusion criteria: INCLUSION CRITERIA: 1) Females of age 25-40 years 2) American Society of Anesthesiologists (ASA) grade I -II patients 3) Body mass index 18 - 30kg/m2 4) Patients undergoing Laparoscopic sterilization surgeries under general anaesthesia
Exclusion criteria
Exclusion criteria: EXCLUSION CRITERIA 1) Known hypersensitivity to any of the study drugs 2) Patients who had previous abdominal surgery and those on magnesium therapy 3) Patients with respiratory, cardiac , liver and renal disorders 4) Patients who are using analgesics, sedatives, beta blockers and anticonvulsants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Objective: 1) To compare the duration of postoperative analgesia among patients undergoing laparoscopic sterilization with intraperitoneal magnesium sulphate plus bupivacaine (MB) and bupivacaine(B) alone Timepoint: baseline,1st hour,2nd hour,4th hour, 6th hour, 8th hour and 12th hour | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To compare the postoperative pain scores 2) To compare the total analgesic intake in first 12hours after surgery 3) To compare the postoperative hemodynamic changes and adverse effects among patients undergoing laparoscopic sterilization with intraperitoneal magnesium sulphate plus bupivacaine (MB) and bupivacaine(B) aloneTimepoint: baseline,1st hour,2nd hour,4th hour, 6th hour, 8th hour and 12th hour | — |
Countries
India
Contacts
Public ContactDR RITHU VARKEY
MALANKARA ORTHODOX SYRIAN CHURCH MEDICAL COLLEGE Medical College
Outcome results
None listed